Research & Development Abingworth LLP
Epsilogen Ltd
Actigen Limited
Freeline Therapeutics Limited
Adrestia Therapeutics Ltd
Grünenthal GmbH
Agenus UK Limited
Healx
Alloy Therapeutics UK Ltd
Higher Steaks Ltd
AMR Centre
Immodulon Therapeutics
Antikor Biopharma
Immune Regulation Limited
Apollo Therapeutics LLP
ImmuPharma
Artios Pharma Limited
Inivata Limited
Astex Pharmaceuticals Ltd
iosBio Ltd
AstraZeneca
Kymab Limited
Autolus Limited
LEX Diagnostics Limited
Babraham Institute Enterprise Limited
LifeArc
Beauchamp Tecnology
Macomics Limited
BenevolentAI
Merck KGaA
BicycleTx Limited
Mestag Therapeutics Limited
Biosceptre UK Limited
Microbiotica
Boehringer Ingelheim
Mission Therapeutics Limited
Cambridge Enterprise Limited
MSD
Cambridge Innovation Capital
Nanna Therapeutics Ltd
Cambridge Rare Disease Network
National Physical Laboratory
CamPhos Therapeutics
Nationwide Laboratories
Cancer Research UK
o2h Ltd
Cancer Research UK-AstraZeneca Antibody
Origin Sciences Limited
Alliance Laboratory
Perfexia Health Technologies Ltd
Capella Bioscience Limited
Phico Therapeutics Ltd
Cerevance Ltd
PhoreMost Ltd
Closed Loop Medicine Limited
PolyProx Therapeutics Ltd
CN Bio Innovations
Public Health England
Daiichi Sankyo Co Ltd
Precision Life
Diosynvax Ltd
Quadram Institute Bioscience
Dr. Reddy’s Laboratories (EU) Ltd
Queen Mary BioEnterprises Ltd
Eli Lilly
Queen Mary Innovation Ltd
EMBL-EBI
Queen Mary University of London
Empyrean Therapeutics Ltd
- (Business Development)
Epidarex Capital
Richmond Research Institute www.onenucleus.com | 45